BioNTech SE (BNTX) Minority Interest (2018)

BioNTech SE (BNTX) reported Minority Interest of $966762.8 for Q4 2018.

BioNTech SE (BNTX) Minority Interest (2018) Analysis & Trends

BioNTech SE (BNTX) has 1 years of Minority Interest data on file, last reported at $966762.8 in Q4 2018.

For the quarter ending Q4 2018, Minority Interest changed N/A year-over-year to $966762.8; the trailing twelve-month figure through Dec 2018 stood at $966762.8 (changed N/A YoY), and the FY2018 full-year result was $1.0 million, changed N/A from the prior year.
Minority Interest was little changed at $966762.8 in Q4 2018.
In the past five years, Minority Interest ranged from a high of $966762.8 in Q4 2018 to a low of $966762.8 in Q4 2018.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	BioNTech SE	22.13 Bn	22.13 Bn	668.28 Mn

Historic Data

Download Data

Date	Value
Dec 31, 2018	966,762.77